Puma Biotechnology filed a lawsuit against AstraZeneca for patent infringement related to Tagrisso, resulting in a jury awarding $107.5 million to Wyeth for past infringement, but AstraZeneca's motion for judgment on patent invalidity was partially granted by the court.